Nasopharyngeal Carcinoma Clinical Trials in Guangzhou, Guangdong
57 recruitingGuangzhou, Guangdong, China
Showing 1–20 of 57 trials
Recruiting
Phase 3
IC Plus Low-dose Radiation Plus Cadonilimab in LANPC
ChemotherapyRadiotherapyImmune Checkpoint Inhibitor+1 more
Sun Yat-sen University380 enrolled3 locationsNCT05941741
Recruiting
Phase 2
A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors
Non-small Cell Lung CancerSolid TumorNasopharyngeal Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.570 enrolled1 locationNCT06475300
Recruiting
Phase 3
Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and Immunotherapy
Nasopharyngeal Carcinoma (NPC)
Ming-Yuan Chen456 enrolled12 locationsNCT07328841
Recruiting
Phase 1Phase 2
A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma.
Recurrent or Metastatic Nasopharyngeal Carcinoma
MediLink Therapeutics (Suzhou) Co., Ltd.202 enrolled20 locationsNCT07258979
Recruiting
Phase 2
A Phase II Study to Evaluate HLX43 in Subjects With Recurrent/Metastatic Nasopharyngeal Carcinoma Failed or Intolerance to Second-line Therapy
Nasopharyngeal Carcinoma (NPC)
Shanghai Henlius Biotech70 enrolled15 locationsNCT06839066
Recruiting
Phase 2
A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors
Non-small Cell Lung CancerNasopharyngeal Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.121 enrolled16 locationsNCT05956587
Recruiting
Phase 3
A Phase III Study of YL201 in Recurrent or Metastatic Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma
MediLink Therapeutics (Suzhou) Co., Ltd.400 enrolled1 locationNCT06629597
Recruiting
Phase 3
PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients
Recurrent Nasopharyngeal Carcinoma
Sun Yat-sen University212 enrolled12 locationsNCT03907826
Recruiting
Not Applicable
Surgery Alone Verus Sugery Combined with Dose-reduced Radiotherapy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma
SurgeryRadiotherapyNasopharyngeal Carcinoma
Ming-Yuan Chen86 enrolled2 locationsNCT06688760
Recruiting
Deep Learning-based sbORN Diagnostic Model
Nasopharyngeal CarcinomaHerpesvirus 4, Human
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University312 enrolled1 locationNCT06463392
Recruiting
Phase 1
Concurrent Nab-paclitaxel with Intensity-modulated Radiation Therapy in Patients with Stage III-IVa Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University24 enrolled1 locationNCT06611150
Recruiting
Not Applicable
Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy
Locally Advanced Nasopharyngeal Carcinoma
First Affiliated Hospital of Guangxi Medical University190 enrolled20 locationsNCT05892354
Recruiting
Phase 3
Efficacy and Safety of TPC+Apatinib+Camrelizumab vs GP+ Camrelizumab for High-Risk Nasopharyngeal Carcinoma: A Phase 3 Trial
Nasopharyngeal Carcinoma
XIANG YANQUN164 enrolled2 locationsNCT06438627
Recruiting
Phase 3
Tislelizumab in Combination With GP or TPC Regimen for the Treatment of Nasopharyngeal Carcinoma With Bone Metastasis.
Nasopharyngeal Carcinoma
XIANG YANQUN90 enrolled1 locationNCT06383780
Recruiting
Phase 2Phase 3
A Multi-center, Randomized, Double-blind, Phase II/III Clinical Trial of AK104 or Placebo in Combination With Chemotherapy as Second-line or More Lines for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)
Recurrent or Metastatic Nasopharyngeal Carcinoma
Sun Yat-sen University300 enrolled1 locationNCT06241599
Recruiting
Phase 3
Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial
Nasopharyngeal Carcinoma
Sun Yat-sen University212 enrolled12 locationsNCT05340491
Recruiting
Epstein-Barr Virus Antibody and Epstein-Barr Virus DNA for Nasopharyngeal Carcinoma Screening
Nasopharyngeal Carcinoma
Sun Yat-sen University11,625 enrolled1 locationNCT05447169
Recruiting
Not Applicable
Surgery Plus Target-reduction Chemoradiotherapy vs Regular Chemoradiotherapy for Newly Diagnosed Resectable Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma
Sun Yat-sen University264 enrolled2 locationsNCT05352321
Recruiting
Phase 3
Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma
Sun Yat-sen University556 enrolled1 locationNCT05342792
Recruiting
Phase 3
Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma
ChemotherapyRadiotherapyNasopharyngeal Carcinoma
Sun Yat-sen University508 enrolled6 locationsNCT04448522